热门资讯> 正文
Ocular Therapeutix 2024年第二季度盈利预览
2024-08-07 00:11
- Ocular Therapeutix (NASDAQ:OCUL) is scheduled to announce Q2 earnings results on Wednesday, August 7th, before market open.
- The consensus EPS Estimate is -$0.21 (+19.2% Y/Y) and the consensus Revenue Estimate is $15.85M (+4.3% Y/Y).
- Over the last 2 years, OCUL has beaten EPS estimates 13% of the time and has beaten revenue estimates 25% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 2 downward. Revenue estimates have seen 1 upward revision and 6 downward.
More on Ocular Therapeutix
- Ocular Therapeutix: A Speculative Investment For Risk-Tolerant Investors
- Investor Day Slides
- Ocular Therapeutix, Inc. (OCUL) Investor Day Call Transcript
- Ocular Therapeutix jumps as TD Cowen upgrades to Buy and hikes PT
- Ocular Therapeutix jumps after investor day updates
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。